You are here: Industry Insights > Drug Pricing

News List

Drug pricing, reimbursement constraints leading impediments to industry growth in 2021: GlobalData expresspharma
January 11, 2021
In 2021, drug pricing pressure from regulators and payers will remain and aggressive negotiation tactics to drive down drug prices will continue, according to GlobalData, a data and analytics company.
Supply chain and drug pricing reform required to lower US healthcare costs europeanpharmaceuticalreview
January 13, 2020
Price caps and government regulations will not lower US healthcare costs, instead supply chain and drug pricing reforms are required, says a brief by medical economist.
WHO adopts resolution on drug pricing transparency pharmaceutical-technology
May 31, 2019
Member countries of the World Health Organization (WHO) have agreed to support pricing transparency for medicines, vaccines and other health products.
Pharmacy benefit managers next up to testify in US Senate hearings on drug pricing firstwordpharma
March 13, 2019
The US Senate Committee on Finance asked executives from five pharmacy benefit manager (PBMs), including CVS Caremark and UnitedHealth's OptumRx unit, to testify at a hearing on April 3 on drug pricing in the country.
Trump’s war on drug pricing looks set to continue pharmaphorum
January 04, 2019
Shrugging off warnings from president Donald Trump, pharma companies have announced US price hikes on more than 250 prescription drugs for 2019....
After New Year's, expect more drug pricing fireworks in 2019 fiercepharma
December 24, 2018
For several years, pharma watchers have witnessed drug pricing grow into a top issue facing the industry, dominating discussion almost daily. The conversation isn’t likely to subside next year, either.
After New Year's, expect more drug pricing fireworks in 2019 fiercepharma
December 24, 2018
For several years, pharma watchers have witnessed drug pricing grow into a top issue facing the industry, dominating discussion almost daily. The conversation isn’t likely to subside next year, either.
New UK drug pricing deal promises faster medicines access pharmaphorum
November 27, 2018
The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the almost 60-year-old Pharmaceutical Price Regulation Scheme (PPRS).
Pfizer, plotting 41 price hikes for January, returns to 'business as normal' after price-raising pause fiercepharma
November 20, 2018
Pfizer, which became the center of a drug pricing controversy this summer featuring President Donald Trump, has decided it’s ready to raise prices in early 2019.
Why This Little Known Biotech Is Pharma's New Poster Child for Price Gouging biospace
December 21, 2017
Following a report in the Washington Post, Sen. Claire McCaskill, a Missouri Democrat, sent a letter to the president of Strongbridge Biopharma regarding the escalating price of Keveyis, a drug that has gone from free of charge to more than $15,000.

Previous page 1 2 Next page